We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Show more
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed...
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (βCocrystalβ or the βCompanyβ) announces completion of enrollment of 78 subjects who were infected with...
FDA feedback following the Companyβs submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a...
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (βCocrystalβ or...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.59 | 38.5620915033 | 1.53 | 2.15 | 1.53 | 35981 | 1.74101961 | CS |
4 | 0.69 | 48.2517482517 | 1.43 | 2.15 | 1.4196 | 16651 | 1.65710127 | CS |
12 | 0.74 | 53.6231884058 | 1.38 | 2.15 | 1.35 | 16276 | 1.54340115 | CS |
26 | 0.25 | 13.3689839572 | 1.87 | 2.15 | 1.325 | 16970 | 1.62136177 | CS |
52 | -0.53 | -20 | 2.65 | 3.285 | 1.325 | 22236 | 2.12859428 | CS |
156 | -11.56 | -84.5029239766 | 13.68 | 17.88 | 1.325 | 661803 | 12.54733266 | CS |
260 | -27.04 | -92.7297668038 | 29.16 | 49.2 | 1.325 | 2049386 | 18.85866316 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions